SCL Science Statistics
Total Valuation
SCL Science has a market cap or net worth of KRW 78.65 billion. The enterprise value is 105.26 billion.
| Market Cap | 78.65B |
| Enterprise Value | 105.26B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCL Science has 33.97 million shares outstanding. The number of shares has increased by 144.11% in one year.
| Current Share Class | 33.97M |
| Shares Outstanding | 33.97M |
| Shares Change (YoY) | +144.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.63% |
| Owned by Institutions (%) | n/a |
| Float | 14.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.82 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 14.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.76 |
| EV / Sales | 6.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.46 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.17 |
| Quick Ratio | 0.92 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.19 |
| Interest Coverage | -3.97 |
Financial Efficiency
Return on equity (ROE) is -16.13% and return on invested capital (ROIC) is -7.43%.
| Return on Equity (ROE) | -16.13% |
| Return on Assets (ROA) | -5.95% |
| Return on Invested Capital (ROIC) | -7.43% |
| Return on Capital Employed (ROCE) | -8.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.33 |
| Inventory Turnover | 12.37 |
Taxes
In the past 12 months, SCL Science has paid 681,990 in taxes.
| Income Tax | 681,990 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.84% in the last 52 weeks. The beta is 0.56, so SCL Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +11.84% |
| 50-Day Moving Average | 2,500.80 |
| 200-Day Moving Average | 2,455.58 |
| Relative Strength Index (RSI) | 35.80 |
| Average Volume (20 Days) | 65,382 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCL Science had revenue of KRW 16.32 billion and -3.66 billion in losses. Loss per share was -123.25.
| Revenue | 16.32B |
| Gross Profit | 3.37B |
| Operating Income | -4.70B |
| Pretax Income | -3.66B |
| Net Income | -3.66B |
| EBITDA | -2.20B |
| EBIT | -4.70B |
| Loss Per Share | -123.25 |
Balance Sheet
The company has 5.39 billion in cash and 29.29 billion in debt, giving a net cash position of -23.90 billion or -703.56 per share.
| Cash & Cash Equivalents | 5.39B |
| Total Debt | 29.29B |
| Net Cash | -23.90B |
| Net Cash Per Share | -703.56 |
| Equity (Book Value) | 28.59B |
| Book Value Per Share | 3,047.42 |
| Working Capital | 3.55B |
Cash Flow
In the last 12 months, operating cash flow was -7.07 billion and capital expenditures -2.11 billion, giving a free cash flow of -9.18 billion.
| Operating Cash Flow | -7.07B |
| Capital Expenditures | -2.11B |
| Free Cash Flow | -9.18B |
| FCF Per Share | -270.29 |
Margins
Gross margin is 20.66%, with operating and profit margins of -28.78% and -22.42%.
| Gross Margin | 20.66% |
| Operating Margin | -28.78% |
| Pretax Margin | -22.42% |
| Profit Margin | -22.42% |
| EBITDA Margin | -13.45% |
| EBIT Margin | -28.78% |
| FCF Margin | n/a |
Dividends & Yields
SCL Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -144.11% |
| Shareholder Yield | -144.11% |
| Earnings Yield | -4.65% |
| FCF Yield | -11.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2025. It was a forward split with a ratio of 4.
| Last Split Date | Jun 30, 2025 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
SCL Science has an Altman Z-Score of 0.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 1 |